Session

NASH and diagnostics (Posters)

MYOSTEATOSIS AND FRAILTY FACTORS ASSOCIATED WITH THE OCCURRENCE OF COMPLICATIONS IN CIRRHOTIC PATIENTS: MYOFACC STUDY
MYOSTEATOSIS AND FRAILTY FACTORS ASSOCIATED WITH THE OCCURRENCE OF COMPLICATIONS IN CIRRHOTIC PATIENTS: MYOFACC STUDY

MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS
MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS

EXTRACELLULAR VESICLES FROM TGR5-ACTIVATED ADIPOCYTES ELICIT ANTI-INFLAMMATORY EFFECTS UPON HEPATOCYTES EXPOSED TO NAFLD-ASSOCIATED PATHOGENIC STIMULI
EXTRACELLULAR VESICLES FROM TGR5-ACTIVATED ADIPOCYTES ELICIT ANTI-INFLAMMATORY EFFECTS UPON HEPATOCYTES EXPOSED TO NAFLD-ASSOCIATED PATHOGENIC STIMULI

FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS
FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS

HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?
HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?

ASSESSMENT OF LIVER FIBROSIS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING COMBINED WITH RESULTS OF MINI-LAPAROSCOPY AND HISTOLOGY EVALUATION: A SINGLE-CENTER TRIAL
ASSESSMENT OF LIVER FIBROSIS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING COMBINED WITH RESULTS OF MINI-LAPAROSCOPY AND HISTOLOGY EVALUATION: A SINGLE-CENTER TRIAL

THE UTILITY OF PENTRAXIN 3 AND PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA AS NON-INVASIVE BIOMARKERS FOR PREDICTION OF CARDIOVASCULAR RISK IN MAFLD PATIENTS
THE UTILITY OF PENTRAXIN 3 AND PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA AS NON-INVASIVE BIOMARKERS FOR PREDICTION OF CARDIOVASCULAR RISK IN MAFLD PATIENTS

QUALITY CRITERIA IN DETECTING LIVER FIBROSIS BY 2D SW ELASTOGRAPHY. DOES THE ETIOLOGY OF LIVER DISEASE MATTER?
QUALITY CRITERIA IN DETECTING LIVER FIBROSIS BY 2D SW ELASTOGRAPHY. DOES THE ETIOLOGY OF LIVER DISEASE MATTER?

THE EFFICACY OF QUERCETIN ADMINISTRATION IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
THE EFFICACY OF QUERCETIN ADMINISTRATION IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS

THE EFFECT OF ROUX-EN-Y GASTRIC BYPASS ON NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS ASSESSED BY FIB-4 AND NFS SCORES - AN 11.6-YEAR FOLLOW-UP-STUDY
THE EFFECT OF ROUX-EN-Y GASTRIC BYPASS ON NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS ASSESSED BY FIB-4 AND NFS SCORES - AN 11.6-YEAR FOLLOW-UP-STUDY

THE EFFECT OF ROUX-EN-Y GASTRIC BYPASS ON NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS ASSESSED BY FIB-4 AND NFS SCORES - AN 11.6-YEAR FOLLOW-UP-STUDY
THE EFFECT OF ROUX-EN-Y GASTRIC BYPASS ON NON-ALCOHOLIC FATTY LIVER DISEASE FIBROSIS ASSESSED BY FIB-4 AND NFS SCORES - AN 11.6-YEAR FOLLOW-UP-STUDY

NASH and diagnostics (Posters)  et al.

THE EFFICACY OF QUERCETIN ADMINISTRATION IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
THE EFFICACY OF QUERCETIN ADMINISTRATION IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS

NASH and diagnostics (Posters)  et al.

QUALITY CRITERIA IN DETECTING LIVER FIBROSIS BY 2D SW ELASTOGRAPHY. DOES THE ETIOLOGY OF LIVER DISEASE MATTER?
QUALITY CRITERIA IN DETECTING LIVER FIBROSIS BY 2D SW ELASTOGRAPHY. DOES THE ETIOLOGY OF LIVER DISEASE MATTER?

NASH and diagnostics (Posters)  et al.

THE UTILITY OF PENTRAXIN 3 AND PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA AS NON-INVASIVE BIOMARKERS FOR PREDICTION OF CARDIOVASCULAR RISK IN MAFLD PATIENTS
THE UTILITY OF PENTRAXIN 3 AND PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA AS NON-INVASIVE BIOMARKERS FOR PREDICTION OF CARDIOVASCULAR RISK IN MAFLD PATIENTS

NASH and diagnostics (Posters)  et al.

ASSESSMENT OF LIVER FIBROSIS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING COMBINED WITH RESULTS OF MINI-LAPAROSCOPY AND HISTOLOGY EVALUATION: A SINGLE-CENTER TRIAL
ASSESSMENT OF LIVER FIBROSIS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING COMBINED WITH RESULTS OF MINI-LAPAROSCOPY AND HISTOLOGY EVALUATION: A SINGLE-CENTER TRIAL

NASH and diagnostics (Posters)  et al.

HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?
HOW MANY AUTO PSWE AND ULTRASOUND DERIVED FAT FRACTION (UDFF) ACQUISITIONS SHOULD WE MAKE IN ORDER TO OBTAIN THE BEST RESULT?

NASH and diagnostics (Posters)  et al.

FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS
FATTY LIVER QUANTIFICATION USING ULTRASOUND DERIVED FAT FRACTION (UDFF) AS COMPARED TO CONTROLLED ATTENUATION PARAMETER (CAP) IN A MIXED COHORT OF PATIENTS

NASH and diagnostics (Posters)  et al.

EXTRACELLULAR VESICLES FROM TGR5-ACTIVATED ADIPOCYTES ELICIT ANTI-INFLAMMATORY EFFECTS UPON HEPATOCYTES EXPOSED TO NAFLD-ASSOCIATED PATHOGENIC STIMULI
EXTRACELLULAR VESICLES FROM TGR5-ACTIVATED ADIPOCYTES ELICIT ANTI-INFLAMMATORY EFFECTS UPON HEPATOCYTES EXPOSED TO NAFLD-ASSOCIATED PATHOGENIC STIMULI

NASH and diagnostics (Posters)  et al.

MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS
MICRORNAS, SEROLOGICAL MARKERS OF LIVER FIBROSIS, HEMATOLOGICAL SCALES, CYTOKERATINS AND GOLGI PROTEIN 73 - A NEW POTENTIAL COMBINATION FOR THE DIAGNOSTICS OF ALCOHOL-RELATED LIVER CIRRHOSIS

NASH and diagnostics (Posters)  et al.

MYOSTEATOSIS AND FRAILTY FACTORS ASSOCIATED WITH THE OCCURRENCE OF COMPLICATIONS IN CIRRHOTIC PATIENTS: MYOFACC STUDY
MYOSTEATOSIS AND FRAILTY FACTORS ASSOCIATED WITH THE OCCURRENCE OF COMPLICATIONS IN CIRRHOTIC PATIENTS: MYOFACC STUDY

NASH and diagnostics (Posters)  et al.

Item 1 - 20 / 20
1